Tushar Beuria

Employment

• Institute of Life Sciences, Bhubaneswar Scientist F and Principal Investigator
  2024 - Present
• Institute of Life Sciences Principal Investigator, Scientist E
  2019 - 2023
• Institute of Life Sciences Scientist D and Principal Investigator
  2015 - 2018
• Institute of Life Sciences Ramalinagaswami Fellow and Principal Investigator
  2011 - 2016

Education

• The University of Texas Health Science Center at Houston Postdoctoral fellow
  2006 - 2011
• Indian Institute of Technology Bombay PhD
  2001 - 2006

Projects & Funding

Projects & funding information is unavailable.

Publications (32)

• Efflux-Mediated Resistance in Staphylococcus aureus: Challenges and Opportunities for Therapeutic Intervention
  Indian Journal of Microbiology 2026 DOI: 10.1007/s12088-026-01545-9
  +Save
• Free-living amoebae predation in nutrient-enriched treated wastewater: ecological potential and machine learning-assisted analysis
  Environmental Technology 2026 DOI: 10.1080/09593330.2026.2709903
  +Save
• 10058-F4 Mediated inhibition of the biofilm formation in multidrug-resistant Staphylococcus aureus
  Biofilm 2025 DOI: 10.1016/j.bioflm.2025.100307
  +Save
• Inhibition of efflux pumps by FDA-approved drugs oxiconazole and sertaconazole restores antibiotic susceptibility in multidrug-resistant S. aureus
  Antimicrobial Agents and Chemotherapy 2025 DOI: 10.1128/aac.00320-25
  +Save
• Efflux pump modulation by Montelukast and its roles in restoring antibiotic susceptibility in multidrug-resistant Staphylococcus aureus
  eBioMedicine 2025 DOI: 10.1016/j.ebiom.2025.105658
  +Save
• The cell division protein ZapE is targeted by the antibiotic aztreonam to induce cell filamentation in Escherichia coli
  FEBS Letters 2023 DOI: 10.1002/1873-3468.14759
  +Save
• FtsE, the Nucleotide Binding Domain of the ABC Transporter Homolog FtsEX, Regulates Septal PG Synthesis in E. coli
  Microbiology Spectrum 2023 DOI: 10.1128/spectrum.02863-22
  +Save
• Long-read 16S-seq reveals nasopharynx microbial dysbiosis and enrichment of Mycobacterium and Mycoplasma in COVID-19 patients: a potential source of co-infection.
  Molecular omics 2022 DOI: 10.1039/d2mo00044j
  +Save
• Isolation and Characterization of Five Severe Acute Respiratory Syndrome Coronavirus 2 Strains of Different Clades and Lineages Circulating in Eastern India.
  Frontiers in microbiology 2022 DOI: 10.3389/fmicb.2022.856913
  +Save
• MBZM-N-IBT, a Novel Small Molecule, Restricts Chikungunya Virus Infection by Targeting nsP2 Protease Activity In Vitro, In Vivo, and Ex Vivo.
  Antimicrobial agents and chemotherapy 2022 DOI: 10.1128/aac.00463-22
  +Save